APA

Zhang X., Brooks B., Molyneaux L., Landy E., Banatwalla R., Wu T., Wong J., Su B. & Yue D. K. (20140902). Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity. : International journal of endocrinology.

Chicago

Zhang X, Brooks B, Molyneaux L, Landy E, Banatwalla R, Wu T, Wong J, Su B and Yue D K. 20140902. Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity. : International journal of endocrinology.

Harvard

Zhang X., Brooks B., Molyneaux L., Landy E., Banatwalla R., Wu T., Wong J., Su B. and Yue D. K. (20140902). Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity. : International journal of endocrinology.

MLA

Zhang X, Brooks B, Molyneaux L, Landy E, Banatwalla R, Wu T, Wong J, Su B and Yue D K. Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity. : International journal of endocrinology. 20140902.